Receptor-mediated, tumor-targeted gene delivery using folate-terminated polyrotaxanes.
Receptor-mediated, tumor-targeted gene delivery using folate-terminated polyrotaxanes.
复制标题
DOI:
10.1021/mp200315c
复制
发表时间:
2012-04
影响因子:
4.9
通讯作者:
Yi Zhou;He Wang;Chengxi Wang;Yue-shan Li;Wenfeng Lu;Shui-fang Chen;Jiandong Luo;Yongnan Jiang;Jian-hai Chen
中科院分区:
文献类型:
--
作者:
Yi Zhou;He Wang;Chengxi Wang;Yue-shan Li;Wenfeng Lu;Shui-fang Chen;Jiandong Luo;Yongnan Jiang;Jian-hai Chen
Safe and effective gene delivery is essential to the success of gene therapy. We synthesized and characterized a novel nonviral gene delivery system in which folate (FA) molecules were functioned as blockers on cationic polyrotaxanes (PR) composed of poly(ethylenimine) (PEI)(600)-grafted α-cyclodextrin rings linearized on polyethylene glycol to form FA-terminated PR-PEI(600) (FPP). The FA terminal caps of FPP target cell surfaces abundant in FA receptor (FR), a common feature of tumor cells. The structure of FPP was characterized by using (1)H nuclear magnetic resonance ((1)H NMR). The delivery particle was composed of chemically bonded PEG (4000), α-cyclodextrins (CD), and PEI (600 Da) at a molar ratio of 1:17:86.7, and the particle size and zeta potential of FPP/pDNA polyplexes were measured using dynamic light scattering. FPP/pDNA exhibited a lower cytotoxicity, strong specificity to FR, and high efficiency of delivering DNA to target cells in vitro and in vivo with the reporter genes. Furthermore, the FPP/DNA complex showed an enhanced antitumor effect in the nude mice compared with other delivery systems, such as PEI-25K. Together, these results suggest that FPP may be useful for gene therapy.